Loading clinical trials...
Loading clinical trials...
The Impact of Percutaneous Patent Foramen Ovale Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine
Conditions
Interventions
Percutaneous Patent Foramen Ovale Closure
No Intervention
Locations
2
China
Luoyang Central Hospital
Luoyang, Henan, China
The Second Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Start Date
January 14, 2026
Primary Completion Date
May 31, 2027
Completion Date
December 31, 2027
Last Updated
January 16, 2026
NCT04715685
NCT07172464
NCT07420400
NCT06590467
NCT06203873
NCT06347276
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions